TickerFacts.

Company research / INDV

Indivior Pharmaceuticals, Inc. (INDV)

Build a valuation ↗↓ Download CSV

CIK 0001625297 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Indivior Pharmaceuticals, Inc. reported revenue of $1.24B. Revenue grew 4.3% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $1.33B.

Key ratios (year ended 2025-12-31)

80.2%
Gross margin
21.1%
Operating margin
16.9%
Net margin
4.3%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-15

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-31
Revenue$1.33B$1.24B$1.19B$1.09B$901.00M
Cost of Revenue$240.00M$246.00M$231.00M$174.00M$151.00M
Gross Profit$1.09B$994.00M$957.00M$919.00M$749.00M
R&D Expense$82.00M$97.00M$107.00M$116.00M$74.00M
Operating Income$421.00M$262.00M$38.00M-$152.00M-$81.00M
Depreciation & Amortization$9.00M$10.00M$16.00M$15.00M$16.00M
EBITDA$430.00M$272.00M$54.00M-$137.00M-$65.00M
Net Income$356.00M$210.00M$7.00M-$126.00M-$44.00M
EPS (Diluted)n/a$1.64$0.05-$0.92-$0.32
Total Assets$1.23B$1.20B$1.32B$1.76Bn/a
Total Liabilities$1.44B$1.30B$1.65B$1.94Bn/a
Shareholders' Equity-$208.00M-$98.00M-$337.00M-$184.00M-$20.00M
Cash & Equivalents$222.00M$195.00M$319.00M$316.00Mn/a
Operating Cash Flow-$40.00M-$27.00M$36.00M-$300.00M-$4.00M
Capital Expenditures$71.00M$66.00M$29.00M$8.00M$5.00M
Free Cash Flow-$111.00M-$93.00M$7.00M-$308.00M-$9.00M
Share Repurchases$302.00M$11.00M$173.00M$33.00M$90.00M
Weighted Average Diluted Sharesn/a128.00M133.00M137.00M139.00M
EPS (Basic)n/a$1.68$0.05-$0.92-$0.32

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView